-
his retrospective review summarizes the clinical outcome and safety among 141 patients who were treated with boric acid and flucytosine for culture-proven Candida glabrata. These data were collected at both Wayne State University School of Medicine and Ben Gurion University.
-
-
Women who initially were diagnosed with Stage IA disease and who had serous borderline tumors or underwent cystectomy appeared to derive the most benefit from restaging surgery. Nonetheless, the indications for restaging surgery remain controversial, as no difference in recurrence rate was observed between women who underwent restaging and those who did not.
-
In this special feature, up-to-date information will be provided regarding the risks and benefits of various diagnostic methods available today for patients of advanced maternal age (AMA).
-
Positive Alendronate Data in Osteoporosis; NSAIDs For Myocardial Infarction; Four-Hour Window for CAP Patients; FDA Actions.
-
In a collective effort from the tumor registries of 4 academic centers, Huh and colleagues accessioned cases of uterine papillary serous carcinoma (UPSC), which, following comprehensive surgical staging, were identified with disease limited to the uterine corpussurgical stage I.
-
-
Recombinant Erythropoietin Products May Stimulate Tumor Growth; Rosuvastatin: Markets Most Potent Statin; FDA Actions.
-
Oligoasthenospermia (male factor infertility) is associated with abnormal genomic imprinting of the sperm, a feature that may predispose to abnormal embryogenesis, including a risk of rare developmental abnormalities and cancer in adulthood, if fertilization occurs, as it may because of the availability of assisted reproductive techniques.
-
